Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease
- PMID: 7585861
- DOI: 10.1016/0149-2918(95)80123-5
Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease
Comment on
-
Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.Clin Ther. 1994 Nov-Dec;16(6):1052-62; discussion 1036. Clin Ther. 1994. PMID: 7697684 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
